Dexxos Participações (DEXP3) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
27 Aug, 2026Executive summary
Net revenue for 1Q26 was R$386.9 million, down 35.9% year-over-year and 7.8% sequentially, reflecting lower sales in both chemical and steel segments.
Adjusted EBITDA reached R$58.5 million, down 33.7% year-over-year but up 62.1% sequentially, with margin improving to 15.1%.
Adjusted net income was R$51.3 million, stable year-over-year and up 132.4% sequentially, with a 13.3% margin.
Net cash position reached R$32.7 million at quarter-end, reversing a net debt position from 1Q25.
The first share buyback program was completed, and a second program was launched, targeting up to 3.6 million shares.
Financial highlights
Gross profit for 1Q26 was R$85.6 million, up 33.5% sequentially but down 19.7% year-over-year; gross margin improved to 22.1%.
SG&A expenses dropped 9.5% year-over-year and 11.3% sequentially, reflecting lower selling and administrative costs.
Adjusted EBITDA margin improved to 15.1% in 1Q26 from 8.6% in 4Q25.
Adjusted net income margin rose to 13.3% in 1Q26 from 5.3% in 4Q25.
Cash and cash equivalents at quarter-end were R$360.6 million, with gross debt at R$329.9 million.
Outlook and guidance
Ongoing ramp-up in specialty resins and expansion in the wood panel market are expected to support future growth in the chemical segment.
The steel segment is targeting operational efficiency and portfolio diversification, especially in the solar market.
The company is monitoring regulatory changes, including tax reform and new dividend taxation, and adapting systems and processes accordingly.
Ongoing investments in innovation and expansion, especially in the chemical segment, are expected to support long-term growth.
Latest events from Dexxos Participações
- Robust growth, expanded capacity, and strong ESG practices drive leadership in core markets.DEXP3
Corporate presentation - Revenue and profit fell, but chemicals growth and strong cash position support diversification.DEXP3
Q2 2024 - Chemicals growth drove strong revenue and profit, while steel margins and EBITDA declined year-over-year.DEXP3
Q3 2024 - Revenue up 3.7% to R$1.81B, but EBITDA and net income fell amid margin and steel segment pressure.DEXP3
Q4 2024 - Net revenue rose 55.5% year-over-year to R$603.2 million, with strong growth in both segments.DEXP3
Q1 2025 - Net revenue rose 45.2% and adjusted EBITDA 16.8% year-over-year, with leverage at 0.3x.DEXP3
Q2 2025 - Net revenue up 30% and net income up 11.5% in 9M25, with margins down but cash and investments strong.DEXP3
Q3 2025 - Revenue up 18% to R$2.14B, margins down, strong cash, and new investments executed.DEXP3
Q4 2025 - Margins and net income improved despite lower revenue, with strong cash and new investments.DEXP3
Q2 2026